LYTIX BIOPHARMA AS

Home - Lytix Biopharma

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: ØR
Øystein Rekdal1962
Chairman of the board: MA
Marie Ann Roskrow1965
Years since formation: 21 years; since Aug 25, 2003
Type: Limited company
VAT registered: Yes
Number of employees: 6

Ownership

Number of shares and share classes: 40,068,319; 1 share class
Total number of shareholders: 1095; 268 companies, 827 persons

Financials

Total operating income 2023: 3,991,213; NOK
Annual total result 2023: -87,897,449; NOK
Total equity 2023: 51,319,307; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
ØR Øystein Rekdal 1962	Managing Director/CEO	-

Board

Name	Role	Shares
BK Brynjar Kristian Forbergskog 1958	Board Member	-
KH Kjetil Hestdal 1960	Board Member	-
EW Evelina Wanda Matilda Vägesjö 1986	Board Member	-
HM Helena Marie-Louise Fjällskog 1964	Board Member	-
JM Jayson Michael Rieger 1975	Board Member	-
MA Marie Ann Roskrow 1965	Chairman	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-
B BDO AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
TA Terje Arnulf Johansen 1955	-	6.61 % indirectly
YN Yngvar Nilssen 1986	-	3.92 % indirectly
BE Bernt Endrerud 1955	-	3.02 % indirectly
LT Linda Therese Hansen 1983	-	2.46 % indirectly
TA Tor Albert Thommesen 1940	-	2.32 % indirectly
UT Unni Thommesen 1943	-	2.32 % indirectly
JH Jakob Hatteland 1951	-	2.3 % indirectly
KE Knut Eidissen 1960	-	1.59 % indirectly
PG Per Grieg 1957	-	1.51 % indirectly
ON Ole-Kristian Nergård 1992	-	1.47 % indirectly

Last update: Jun 10, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
NC Na Citibank	NO0010405780	3,690,417	9.21 %
J JAKOB HATTELAND HOLDING AS	NO0010405780	3,000,000	7.49 %
W WAATVIKA AS	NO0010405780	1,860,764	4.64 %
T TAJ HOLDING AS	NO0010405780	1,834,702	4.58 %
L LYR INVEST AS	NO0010405780	1,770,925	4.42 %
B BRØDRENE KARLSEN HOLDING AS	NO0010405780	1,709,274	4.27 %
C CARE HOLDING AS	NO0010405780	1,208,080	3.02 %
Y YNNI INVEST AS	NO0010405780	1,202,049	3 %
P PER STRAND EIENDOM AS	NO0010405780	1,024,128	2.56 %
L LTH INVEST AS	NO0010405780	801,366	2 %
P PICASSO AS	NO0010405780	695,753	1.74 %
ES Enskilda Banken Ab Skandinaviska	NO0010405780	669,115	1.67 %
L LYSNES INVEST AS	NO0010405780	615,654	1.54 %
K KVASSHØGDI AS	NO0010405780	604,727	1.51 %
B BELVEDERE AS	NO0010405780	569,591	1.42 %
N NORINNOVA INVEST AS	NO0010405780	557,510	1.39 %
S SATURN INVEST AS	NO0010405780	555,555	1.39 %
H HIFO INVEST AS	NO0010405780	555,555	1.39 %
N NORTH MURRAY AS	NO0010405780	516,814	1.29 %
J JAHATT AS	NO0010405780	500,000	1.25 %
H HOPEN INVEST AS	NO0010405780	481,117	1.2 %
N NORDNET LIVSFORSIKRING AS	NO0010405780	387,163	0.97 %
D DRAGESUND INVEST AS	NO0010405780	300,000	0.75 %
BN Bank Ab Nordnet	NO0010405780	282,659	0.71 %
H HARILA INVEST AS	NO0010405780	275,680	0.69 %
PO Per Ove Løkke Pettersen 1985	NO0010405780	270,000	0.67 %
L LUKAS I AS	NO0010405780	226,015	0.56 %
K KREFTFORENINGEN	NO0010405780	218,000	0.54 %
S SALTHAVN AS	NO0010405780	211,111	0.53 %
F FREWI AS	NO0010405780	200,010	0.5 %
J JPB AS	NO0010405780	200,000	0.5 %
S STEIN TORE GUSTAVSEN AS	NO0010405780	193,008	0.48 %
J JESEM AS	NO0010405780	170,085	0.42 %
H HERSETH AS	NO0010405780	170,000	0.42 %
H HEYERN AS	NO0010405780	167,230	0.42 %
G GH HOLDING AS	NO0010405780	166,666	0.42 %
N NYHAMN AS	NO0010405780	166,666	0.42 %
F FM HOLDING AS	NO0010405780	166,666	0.42 %
JE Jan Eyvin Wang 1956	NO0010405780	160,831	0.4 %
4 4 LB INVEST AS	NO0010405780	160,040	0.4 %
T TAVE INVEST AS	NO0010405780	156,488	0.39 %
N NORINNOVA AS	NO0010405780	155,790	0.39 %
P PHARMAPATENT AS	NO0010405780	152,420	0.38 %
S SPAREBANK 1 NORD-NORGE PORTEFØLJE AS	NO0010405780	151,820	0.38 %
S SEAFOOD HOLDING AS	NO0010405780	150,000	0.37 %
B BLOKMAR AS	NO0010405780	140,000	0.35 %
ØR Øystein Rekdal 1962	NO0010405780	139,963	0.35 %
S SÅKORNINVEST MIDT-NORGE AS	NO0010405780	133,790	0.33 %
C COUSI INVEST AS	NO0010405780	130,132	0.32 %
BN Bank Abp Nordea	NO0010405780	125,922	0.31 %
AE Alf Erik Damsgård 1958	NO0010405780	124,648	0.31 %
JE Jon Figenschou Eriksen 1946	NO0010405780	118,000	0.29 %
A AGIR AS	NO0010405780	116,621	0.29 %
K KRÆMER AS	NO0010405780	108,000	0.27 %
Ø ØKSNES INVEST AS	NO0010405780	106,180	0.26 %
DR David Rabib 1973	NO0010405780	104,790	0.26 %
B BGB INVEST AS	NO0010405780	101,000	0.25 %
KB Kai Wiggo Berger 1946	NO0010405780	100,835	0.25 %
AS Ab Swedbank	NO0010405780	100,371	0.25 %
S SØRLIA HOLDING AS	NO0010405780	100,000	0.25 %
E ELHATT AS	NO0010405780	100,000	0.25 %
N NEW LINK AS	NO0010405780	100,000	0.25 %
V VEKTOR-E A/S	NO0010405780	100,000	0.25 %
S SPIRALEN HOLDING AS	NO0010405780	100,000	0.25 %
SV Sigurd Heggstad Vinje 1979	NO0010405780	99,339	0.25 %
T TROMS KRAFT AS	NO0010405780	93,730	0.23 %
T TANANGER HOLDING AS	NO0010405780	90,000	0.22 %
D DR. RABIB HOLDING AS	NO0010405780	85,075	0.21 %
ØM Øystein Magnus Albertsen 1956	NO0010405780	85,000	0.21 %
M MOTOR TRADE EIENDOM OG FINANS AS	NO0010405780	84,966	0.21 %
TI Torstein Ingvald Tvenge 1952	NO0010405780	81,406	0.2 %
T TRIM INVEST AS	NO0010405780	81,170	0.2 %
S SPARLI AS	NO0010405780	80,000	0.2 %
I ISTI AS	NO0010405780	80,000	0.2 %
KK Krzysztof Karol Staskiewicz 1980	NO0010405780	79,809	0.2 %
H HØSE AS	NO0010405780	74,530	0.19 %
GØ Gunnar Øye 1965	NO0010405780	73,000	0.18 %
M MEDIANORD AS	NO0010405780	72,829	0.18 %
A ADVOKATFIRMA SYVERTSEN AS	NO0010405780	69,738	0.17 %
BA Bank Ab Avanza	NO0010405780	67,905	0.17 %
M MYRBAKK EIENDOM AS	NO0010405780	67,860	0.17 %
K KRANE AS	NO0010405780	67,860	0.17 %
JH Jan Heggelund 1959	NO0010405780	66,990	0.17 %
EE Einar Arnfred Edvardsen 1946	NO0010405780	65,000	0.16 %
SS Sis Ag Six	NO0010405780	65,000	0.16 %
N NUORA HOLDING AS	NO0010405780	64,150	0.16 %
A AMARONE HOLDING AS	NO0010405780	63,480	0.16 %
SU Switzerland Ag Ubs	NO0010405780	63,143	0.16 %
UK Ulf Kristian Henriksen 1947	NO0010405780	62,845	0.16 %
EL Eline L'abée-Lund 1976	NO0010405780	62,000	0.15 %
K KEWA INVEST AS	NO0010405780	61,290	0.15 %
SH Svein Harald Berntsen 1952	NO0010405780	61,000	0.15 %
L LØNNUM EIENDOM AS	NO0010405780	60,879	0.15 %
SC Suisse Ag Dublin Branch Credit	NO0010405780	60,000	0.15 %
W WITH INVEST AS	NO0010405780	56,701	0.14 %
J JACO NOR AS	NO0010405780	56,700	0.14 %
H HOLTA & CO. AS	NO0010405780	56,700	0.14 %
S SLETTEFJELL INVEST AS	NO0010405780	56,700	0.14 %
OV Odd Viggo Mølmann 1961	NO0010405780	56,700	0.14 %
E EBB HOLDING AS	NO0010405780	56,700	0.14 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	3,991,213	17,273,000	25,827,000
Annual Total Result	-87,897,449	-56,007,000	-48,048,000
Total assets	63,874,065	152,017,000	202,962,000
Total liabilities	12,554,758	16,891,000	13,338,000
Total equity	51,319,307	135,126,000	189,624,000

P&L

Year	2023	2022	2021
Total operating income	3,991,213	17,273,000	25,827,000
Total operating costs	100,775,794	82,969,000	73,843,000
Operating result	-96,784,582	-65,696,000	-48,016,000
Financial income/costs	8,887,133	9,689,000	-32,000
Profit before tax	-87,897,449	-56,007,000	-48,048,000
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-87,897,449	-56,007,000	-48,048,000

Balance overview

Year	2023	2022	2021
Total fixed assets	548,491	124,000	0
Total current assets	63,325,574	151,893,000	202,962,000
Total assets	63,874,065	152,017,000	202,962,000
Short term debt	12,514,171	16,891,000	13,338,000
Long term debt	40,587	0	0
Total liabilities	12,554,758	16,891,000	13,338,000
Contributed capital	51,319,307	135,126,000	189,624,000
Retained earnings	0	0	0
Total equity	51,319,307	135,126,000	189,624,000
Total equity and liabilities	63,874,065	152,017,000	202,962,000

LYTIX BIOPHARMA AS985 889 635